These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


633 related items for PubMed ID: 21410370

  • 1. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
    Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, Vrakking MM, Wang K, Mahoney EM, Audi S, Leadley K, Dawkins KD, Kappetein AP, Synergy between PCI with Taxus and Cardiac Surgery Investigators.
    N Engl J Med; 2011 Mar 17; 364(11):1016-26. PubMed ID: 21410370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    Abdallah MS, Wang K, Magnuson EA, Osnabrugge RL, Kappetein AP, Morice MC, Mohr FA, Serruys PW, Cohen DJ, SYNTAX Trial Investigators.
    J Am Coll Cardiol; 2017 Apr 25; 69(16):2039-2050. PubMed ID: 28427580
    [Abstract] [Full Text] [Related]

  • 4. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
    Abdallah MS, Wang K, Magnuson EA, Spertus JA, Farkouh ME, Fuster V, Cohen DJ, FREEDOM Trial Investigators.
    JAMA; 2013 Oct 16; 310(15):1581-90. PubMed ID: 24129463
    [Abstract] [Full Text] [Related]

  • 5. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
    Zhang Z, Weintraub WS, Mahoney EM, Spertus JA, Booth J, Nugara F, Stables RH, Vaccarino V.
    Am J Cardiol; 2004 Feb 15; 93(4):404-9. PubMed ID: 14969611
    [Abstract] [Full Text] [Related]

  • 6. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
    Zhang Z, Mahoney EM, Stables RH, Booth J, Nugara F, Spertus JA, Weintraub WS.
    Circulation; 2003 Oct 07; 108(14):1694-700. PubMed ID: 12975252
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass.
    Borkon AM, Muehlebach GF, House J, Marso SP, Spertus JA.
    Ann Thorac Surg; 2002 Nov 07; 74(5):1526-30; discussion 1530. PubMed ID: 12440603
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW, SYNTAX Trial Investigators.
    Circulation; 2014 Sep 30; 130(14):1146-57. PubMed ID: 25085960
    [Abstract] [Full Text] [Related]

  • 9. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z, Mahoney EM, Spertus JA, Booth J, Nugara F, Kolm P, Stables RH, Weintraub WS.
    Am Heart J; 2006 Dec 30; 152(6):1153-60. PubMed ID: 17161069
    [Abstract] [Full Text] [Related]

  • 10. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ, Chinnakondepalli K, Magnuson EA, Kandzari DE, Puskas JD, Ben-Yehuda O, van Es GA, Taggart DP, Morice MC, Lembo NJ, Brown WM, Banning A, Simonton CA, Kappetein AP, Sabik JF, Serruys PW, Stone GW, Cohen DJ, EXCEL Investigators.
    J Am Coll Cardiol; 2017 Dec 26; 70(25):3113-3122. PubMed ID: 29097293
    [Abstract] [Full Text] [Related]

  • 11. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.
    Spertus JA, Nerella R, Kettlekamp R, House J, Marso S, Borkon AM, Rumsfeld JS.
    Circulation; 2005 Feb 15; 111(6):768-73. PubMed ID: 15699258
    [Abstract] [Full Text] [Related]

  • 12. Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.
    McGrath BM, Norris CM, Hardwicke-Brown E, Welsh RC, Bainey KR.
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul 01; 3(3):216-223. PubMed ID: 28838087
    [Abstract] [Full Text] [Related]

  • 13. Trial of everolimus-eluting stents or bypass surgery for coronary disease.
    Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK, BEST Trial Investigators.
    N Engl J Med; 2015 Mar 26; 372(13):1204-12. PubMed ID: 25774645
    [Abstract] [Full Text] [Related]

  • 14. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.
    Morice MC, Serruys PW, Kappetein AP, Feldman TE, Ståhle E, Colombo A, Mack MJ, Holmes DR, Choi JW, Ruzyllo W, Religa G, Huang J, Roy K, Dawkins KD, Mohr F.
    Circulation; 2014 Jun 10; 129(23):2388-94. PubMed ID: 24700706
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ, SYNTAX trial investigators.
    Heart; 2015 Dec 10; 101(24):1980-8. PubMed ID: 26552756
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
    Fearon WF, Zimmermann FM, Ding VY, Zelis JM, Piroth Z, Davidavicius G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B, Desai M, Hlatky MA, FAME 3 Investigators.
    Circulation; 2022 May 31; 145(22):1655-1662. PubMed ID: 35369704
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW.
    Eur Heart J; 2014 Oct 21; 35(40):2821-30. PubMed ID: 24849105
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.